Corpus Intelligence IC Memo — LOUISIANA BEHAVIORAL HEALTH AMEND #1 2026-04-26 08:04 UTC
IC Memo — LOUISIANA BEHAVIORAL HEALTH AMEND #1
Investment Committee Memorandum | LA | 89 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LOUISIANA BEHAVIORAL HEALTH AMEND #1

CCN 194116 | CADDO PARISH, LA | 89 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

LOUISIANA BEHAVIORAL HEALTH AMEND #1 is a 89-bed community hospital in CADDO PARISH, LA with $18.5M in net patient revenue and a -3.4% operating margin. The hospital serves a payer mix of 11.7% Medicare, 0.0% Medicaid, and 88.3% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.4% to 3.9% (+736bps).

Net Revenue HCRIS$18.5M
Current EBITDA COMPUTED$-635K
Operating Margin COMPUTED-3.4%
Occupancy HCRIS72.6%
Revenue / Bed COMPUTED$208K
Net-to-Gross HCRIS50.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
48
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -3.4% places it above the state median. Among 48 size-comparable peers (44-178 beds), the median margin is -4.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (44-178), prioritizing same-state peers. 48 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LOUISIANA BEHAVIORAL HEALTH AM (Target)LA89$18.5M-3.4%
OCHSNER MEDICAL CENTER - BATONLA171$371.4M-11.5%
THIBODAUX REGIONAL HEALTH SYSTLA164$244.9M-1.7%
TERREBONNE GENERAL HEALTH SYSTLA139$230.6M-8.3%
OCHSNER MEDICAL CENTER - KENNELA115$193.8M-2.9%
ST. PATRICK HOSPITALLA100$189.4M-7.4%
OPELOUSAS GENERAL HOSPITALLA151$168.5M-12.7%
UNIVERSITY HOSPITAL & CLINICSLA52$158.9M-33.4%
OCHSNER MEDICAL CENTER -NORTHSLA150$107.3M-5.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$388K+210bp18mo
Cost to Collect4.5%2.5%$370K+200bp12mo
Denial Rate Reduction12.0%6.5%$366K+198bp12mo
A/R Days Reduction5200.0%3800.0%$225K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$388K
Cost to Collect
$370K
Denial Rate Reduction
$366K
A/R Days Reduction
$225K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-635K
+ RCM Uplift+$1.4M
Pro Forma EBITDA$726K
Current Margin-3.4%
Pro Forma Margin3.9%
WC Released (1x)$710K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-978K$9.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-978K$10.0M0.00x-100.0%
Bull Case9.0x11.0x$-880K$14.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-880K$15.3M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$2.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$2.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 48 hospitals with 44-178 beds
  • Same-state prioritization (n=49)
  • Comp margins: P25=-27.4% / P50=-4.9% / P75=4.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.